407 related articles for article (PubMed ID: 16136161)
1. Gene therapy progress and prospects: fetal gene therapy--first proofs of concept--some adverse effects.
Coutelle C; Themis M; Waddington SN; Buckley SM; Gregory LG; Nivsarkar MS; David AL; Peebles D; Weisz B; Rodeck C
Gene Ther; 2005 Nov; 12(22):1601-7. PubMed ID: 16136161
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for the fetus: is there a future?
David AL; Peebles D
Best Pract Res Clin Obstet Gynaecol; 2008 Feb; 22(1):203-18. PubMed ID: 17900991
[TBL] [Abstract][Full Text] [Related]
3. The sheep model of in utero gene therapy.
Porada CD; Park P; Almeida-Porada G; Zanjani ED
Fetal Diagn Ther; 2004; 19(1):23-30. PubMed ID: 14646413
[TBL] [Abstract][Full Text] [Related]
4. On the scientific and ethical issues of fetal somatic gene therapy.
Coutelle C; Rodeck C
Gene Ther; 2002 Jun; 9(11):670-3. PubMed ID: 12032684
[TBL] [Abstract][Full Text] [Related]
5. Monitoring for potential adverse effects of prenatal gene therapy: use of large animal models with relevance to human application.
Mehta V; Abi-Nader KN; Carr D; Wallace J; Coutelle C; Waddington SN; Peebles D; David AL
Methods Mol Biol; 2012; 891():291-328. PubMed ID: 22648778
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B.
Schneider H; Adebakin S; Themis M; Cook T; Douar AM; Pavirani A; Coutelle C
J Gene Med; 1999; 1(6):424-32. PubMed ID: 10753068
[TBL] [Abstract][Full Text] [Related]
7. Fetal gene therapy: opportunities and risks.
Wagner AM; Schoeberlein A; Surbek D
Adv Drug Deliv Rev; 2009 Aug; 61(10):813-21. PubMed ID: 19426772
[TBL] [Abstract][Full Text] [Related]
8. Long-term transgene expression by administration of a lentivirus-based vector to the fetal circulation of immuno-competent mice.
Waddington SN; Mitrophanous KA; Ellard FM; Buckley SM; Nivsarkar M; Lawrence L; Cook HT; Al-Allaf F; Bigger B; Kingsman SM; Coutelle C; Themis M
Gene Ther; 2003 Aug; 10(15):1234-40. PubMed ID: 12858188
[TBL] [Abstract][Full Text] [Related]
9. Stem cell and genetic therapies for the fetus.
Roybal JL; Santore MT; Flake AW
Semin Fetal Neonatal Med; 2010 Feb; 15(1):46-51. PubMed ID: 19540822
[TBL] [Abstract][Full Text] [Related]
10. In utero gene therapy: current challenges and perspectives.
Waddington SN; Kramer MG; Hernandez-Alcoceba R; Buckley SM; Themis M; Coutelle C; Prieto J
Mol Ther; 2005 May; 11(5):661-76. PubMed ID: 15851005
[TBL] [Abstract][Full Text] [Related]
11. Fetal muscle gene therapy/gene delivery in large animals.
Abi-Nader KN; David AL
Methods Mol Biol; 2011; 709():239-56. PubMed ID: 21194032
[TBL] [Abstract][Full Text] [Related]
12. Successful expression of beta-galactosidase and factor IX transgenes in fetal and neonatal sheep after ultrasound-guided percutaneous adenovirus vector administration into the umbilical vein.
Themis M; Schneider H; Kiserud T; Cook T; Adebakin S; Jezzard S; Forbes S; Hanson M; Pavirani A; Rodeck C; Coutelle C
Gene Ther; 1999 Jul; 6(7):1239-48. PubMed ID: 10455432
[TBL] [Abstract][Full Text] [Related]
13. Prospects for human gene therapy.
Karson EM; Polvino W; Anderson WF
J Reprod Med; 1992 Jun; 37(6):508-14. PubMed ID: 1619603
[TBL] [Abstract][Full Text] [Related]
14. In utero stem cell transplantation for the treatment of genetic diseases.
Flake AW
Schweiz Med Wochenschr; 1999 Nov; 129(46):1733-9. PubMed ID: 10603645
[TBL] [Abstract][Full Text] [Related]
15. Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice.
Themis M; Waddington SN; Schmidt M; von Kalle C; Wang Y; Al-Allaf F; Gregory LG; Nivsarkar M; Themis M; Holder MV; Buckley SM; Dighe N; Ruthe AT; Mistry A; Bigger B; Rahim A; Nguyen TH; Trono D; Thrasher AJ; Coutelle C
Mol Ther; 2005 Oct; 12(4):763-71. PubMed ID: 16084128
[TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
17. Highly efficient EIAV-mediated in utero gene transfer and expression in the major muscle groups affected by Duchenne muscular dystrophy.
Gregory LG; Waddington SN; Holder MV; Mitrophanous KA; Buckley SM; Mosley KL; Bigger BW; Ellard FM; Walmsley LE; Lawrence L; Al-Allaf F; Kingsman S; Coutelle C; Themis M
Gene Ther; 2004 Jul; 11(14):1117-25. PubMed ID: 15141156
[TBL] [Abstract][Full Text] [Related]
18. Monitoring for potential adverse effects of prenatal gene therapy: genotoxicity analysis in vitro and on small animal models ex vivo and in vivo.
Themis M
Methods Mol Biol; 2012; 891():341-70. PubMed ID: 22648780
[TBL] [Abstract][Full Text] [Related]
19. Organ targeted prenatal gene therapy--how far are we?
Mehta V; Abi Nader K; Waddington S; David AL
Prenat Diagn; 2011 Jul; 31(7):720-34. PubMed ID: 21618255
[TBL] [Abstract][Full Text] [Related]
20. Fetal and neonatal gene therapy: benefits and pitfalls.
Waddington SN; Kennea NL; Buckley SM; Gregory LG; Themis M; Coutelle C
Gene Ther; 2004 Oct; 11 Suppl 1():S92-7. PubMed ID: 15454963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
